Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 1,310,200 | 1,376,000 | 1,216,600 | 1,191,700 | 1,140,900 |
| Cost of Goods | 311,700 | 334,300 | 293,400 | 296,300 | 281,000 |
| Gross Profit | 998,500 | 1,041,700 | 923,200 | 895,400 | 859,900 |
| Operating Expenses | 608,900 | 499,900 | 540,100 | 544,300 | 502,100 |
| Operating Income | 390,300 | 542,100 | 383,500 | 351,400 | 357,800 |
| Other Income | 600 | 3,400 | 5,800 | 4,700 | 6,500 |
| Pre-tax Income | 390,900 | 545,500 | 389,300 | 356,100 | 364,300 |
| Income Tax | 50,800 | 56,000 | 51,100 | 46,600 | 39,100 |
| Net Income Continuous | 340,100 | 489,500 | 338,200 | 309,500 | 325,200 |
| Net Income | $340,100 | $489,500 | $338,200 | $309,500 | $325,200 |
| EPS Basic Total Ops | 0.55 | 0.79 | 0.54 | 0.50 | 0.52 |
| EPS Basic Continuous Ops | 0.55 | 0.79 | 0.54 | 0.50 | 0.52 |
| EPS Diluted Total Ops | 0.54 | 0.78 | 0.54 | 0.49 | 0.52 |
| EPS Diluted Continuous Ops | 0.54 | 0.78 | 0.54 | 0.50 | 0.52 |
| EBITDA(a) | $423,900 | $577,900 | $415,900 | $384,000 | $383,400 |